alfuzosin-teva
teva pharma b.v. - alfuzozinas - pailginto atpalaidavimo tabletės - 10 mg - alfuzosin
symkevi
vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cistinė fibrozė - kiti kvėpavimo sistemos produktai - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.
silungo
norameda, uab - sildenafilis - plėvele dengtos tabletės - 20 mg - sildenafil
oxycodone kalceks
as kalceks - oksikodono hidrochloridas - injekcinis ar infuzinis tirpalas - 10 mg/ml - oxycodone
oxycodone kalceks
as kalceks - oksikodono hidrochloridas - injekcinis ar infuzinis tirpalas - 50 mg/ml - oxycodone
torzelip
zentiva k.s. - ezetimibas/atorvastatinas - tabletės - 10 mg/10 mg - atorvastatin and ezetimibe
torzelip
zentiva k.s. - ezetimibas/atorvastatinas - tabletės - 10 mg/20 mg - atorvastatin and ezetimibe
torzelip
zentiva k.s. - ezetimibas/atorvastatinas - tabletės - 10 mg/40 mg - atorvastatin and ezetimibe
torzelip
zentiva k.s. - ezetimibas/atorvastatinas - tabletės - 10 mg/80 mg - atorvastatin and ezetimibe
dasatinib norameda
norameda, uab - dazatinibas - plėvele dengtos tabletės - 20 mg - dasatinib